MetaCap

Sol-Gel Technologies Ltd. Company Profile

NASDAQ: SLGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

55.17+1.09 (+2.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Sol-Gel Technologies at a glance

Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ness Ziona, Israel. Sol-Gel Technologies is led by Mr. Moshe Arkin and employs about 28 people. The company's shares have traded publicly since 2018.

At a market capitalization of $180.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001684693, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Sol-Gel Technologies do?

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Business description based on the company's public filings.

Company information

Legal name
Sol-Gel Technologies Ltd.
Ticker
NASDAQ: SLGL
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Moshe Arkin
Employees
28
Headquarters
7 Golda Meir Street, Ness Ziona, Israel
Phone
972 8 931 3433
IPO year
2018
Market cap
$180.63M
SEC CIK
0001684693

Companies similar to Sol-Gel Technologies

SLGL peer companies
CompanyPrice% ChgMarket capCompare
WHWKWhitehawk Therapeutics Inc.3.07-1.60%$181.16Mvs SLGL
ADCTADC Therapeutics SA1.28-1.54%$180.05Mvs SLGL
NATRNature's Sunshine Products Inc.10.18+0.10%$176.41Mvs SLGL
VOGXVogenx Inc11.87-7.30%$176.33Mvs SLGL
RNACCartesian Therapeutics Inc.6.14+4.24%$187.29Mvs SLGL
SIGASIGA Technologies Inc.2.40-9.43%$172.45Mvs SLGL
TRDAEntrada Therapeutics Inc.4.35-6.25%$170.30Mvs SLGL
ANTXAN2 Therapeutics Inc.5.08-2.68%$192.75Mvs SLGL

Related